1
|
Rigalleau V, Larroumet A, Ducos C, Rigo M, Barbet-Massin MA, Majchrzak C, Mohammedi K, Baillet-Blanco L, Monlun M, Rami-Arab L, Foussard N. Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure. J Diabetes Complications 2022; 36:108234. [PMID: 35752528 DOI: 10.1016/j.jdiacomp.2022.108234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 06/15/2022] [Accepted: 06/15/2022] [Indexed: 11/16/2022]
Abstract
OBJECTIVE In long-lasting diabetes, a dramatic reduction of HbA1c can precede adverse events such as worsening retinopathies or painful neuropathies. We have now analyzed its possible link with later cardiovascular events in subjects with type 2 diabetes, according to their long-term glucose exposure evaluated by skin autofluorescence (SAF) measured with an AGE-READER (Diagnoptics, Groningen, The Netherland). RESEARCH DESIGN AND METHODS We studied retrospectively a cohort of patients hospitalized for uncontrolled and/or complicated type 2 diabetes from 2009 to 2017. A previous dramatic reduction of HbA1c was defined by more than -1.5 %/4 months, and later cardiovascular events as myocardial infarction, stroke, revascularization procedures, and cardiovascular-related death. Survival analyses were performed before and after categorizing the subjects for their SAF. RESULTS The 386 subjects were 57.5 % men, 62 ± 9 years old, with a 14 ± 9 years duration of diabetes, most were treated by insulin (63.7 %). The dramatic HbA1c reducers (-3.0 ± 1.5 %) represented 16.5 % of the population. During the 51 months (IQR: 30-71) of follow-up, 53 cardiovascular events occurred and were related to the SAF (2.70 ± 0.64 AUs). Linkage was established between the SAF, the reduction of HbA1c and the cardiovascular events (p = 0.017). With a SAF higher than the median (2.65 AUs), the dramatic reduction of HbA1c was related to later cardiovascular events (HR: 3.84, 95%CI: 1.68-8.76). CONCLUSIONS A dramatic decline of HbA1c leads to a higher risk of cardiovascular events in hospitalized subjects with type 2 diabetes and a high long-term glucose exposure.
Collapse
Affiliation(s)
- Vincent Rigalleau
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France; INSERM U1219 - Bordeaux Population Health Research Center, F-33000 Bordeaux, France.
| | - Alice Larroumet
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | - Claire Ducos
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | - Marine Rigo
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | | | - Camille Majchrzak
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | - Kamel Mohammedi
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France; INSERM U1219 - Bordeaux Population Health Research Center, F-33000 Bordeaux, France
| | | | - Marie Monlun
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | - Lila Rami-Arab
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| | - Ninon Foussard
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, F-33600 Pessac, France
| |
Collapse
|
2
|
Rigalleau V, Larroumet A, Mohammedi K, Baillet-Blanco L, Monlun M, Delyfer MN, Korobelnik JF, Foussard N. Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518-2526. Diabetes Care 2022; 45:e60. [PMID: 35245355 DOI: 10.2337/dc21-2254] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Vincent Rigalleau
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, Bordeaux, France.,Department of Ophthalmology, CHU de Bordeaux, Bordeaux, France.,Bordeaux Population Health Research Center, Team LEHA, INSERM, UMR 1219, University of Bordeaux, Bordeaux, France
| | - Alice Larroumet
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, Bordeaux, France.,Department of Ophthalmology, CHU de Bordeaux, Bordeaux, France.,Bordeaux Population Health Research Center, Team LEHA, INSERM, UMR 1219, University of Bordeaux, Bordeaux, France
| | | | - Marie Monlun
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, Bordeaux, France
| | - Marie-Noelle Delyfer
- Department of Ophthalmology, CHU de Bordeaux, Bordeaux, France.,Bordeaux Population Health Research Center, Team LEHA, INSERM, UMR 1219, University of Bordeaux, Bordeaux, France
| | - Jean-François Korobelnik
- Department of Ophthalmology, CHU de Bordeaux, Bordeaux, France.,Bordeaux Population Health Research Center, Team LEHA, INSERM, UMR 1219, University of Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, Bordeaux, France
| |
Collapse
|
3
|
Rigalleau V, Barbet-Massin MA, Larroumet A, Mohammedi K, Baillet-Blanco L, Monlun M, Cherifi B, Foussard N. Comment on Sjöholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444-450. Diabetes Care 2022; 45:e72. [PMID: 35245352 DOI: 10.2337/dc21-2477] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
4
|
Rigalleau V, Larroumet A, Mohammedi K, Baillet-Blanco L, Monlun M, Delyfer MN, Korobelnik JF, Foussard N. Comment on Ipp and Kumar. A Clinical Conundrum: Intensifying Glucose Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care 2021;44:2192-2193. Diabetes Care 2022; 45:e39. [PMID: 35050369 DOI: 10.2337/dc21-2071] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Accepted: 10/08/2021] [Indexed: 02/03/2023]
Affiliation(s)
- Vincent Rigalleau
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Department of Ophthalmology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Universitaire de Bordeaux, INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, France
| | - Alice Larroumet
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Department of Ophthalmology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Universitaire de Bordeaux, INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, France
| | - Laurence Baillet-Blanco
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Marie-Noelle Delyfer
- Department of Ophthalmology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Universitaire de Bordeaux, INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, France
| | - Jean-François Korobelnik
- Department of Ophthalmology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.,Universitaire de Bordeaux, INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, France
| | - Ninon Foussard
- Department of Endocrinology-Diabetology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| |
Collapse
|
5
|
Bertrand A, Foussard N, Monlun M, Blanco L, Mohammedi K, Rigalleau V. RE: "ALBUMINURIA, KIDNEY FUNCTION, AND CANCER RISK IN THE COMMUNITY". Am J Epidemiol 2021; 190:949-950. [PMID: 33305797 DOI: 10.1093/aje/kwaa265] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Revised: 10/05/2020] [Accepted: 10/13/2020] [Indexed: 12/23/2022] Open
|
6
|
Larroumet A, Molina O, Foussard N, Monlun M, Blanco L, Mohammedi K, Rigalleau V. Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia. Diabetes Care 2021;44:e55-e56. Diabetes Care 2021; 44:e110-e111. [PMID: 33972326 DOI: 10.2337/dc21-0287] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Alice Larroumet
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Oceane Molina
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Ninon Foussard
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Marie Monlun
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Kamel Mohammedi
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| | - Vincent Rigalleau
- Endocrinology-Diabetology-Nutrition, Bordeaux CHU and University, Bordeaux, France
| |
Collapse
|
7
|
Rojubally S, Simoneau A, Monlun M, Foussard N, Blanco L, Domenge F, Mohammedi K, Ducasse E, Caradu C, Rigalleau V. For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations. J Diabetes Complications 2021; 35:107808. [PMID: 33386214 DOI: 10.1016/j.jdiacomp.2020.107808] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Revised: 11/02/2020] [Accepted: 11/11/2020] [Indexed: 11/27/2022]
Abstract
We searched whether the accumulation of Advanced Glycation End-products (AGEs), reflected by the skin autofluorescence (SAF), could predict diabetic foot ulcers (DFUs) during the long-term follow-up of people with type 1 diabetes. During year 2009, we measured the SAF with an AGE-Reader in 206 subjects with type 1 diabetes. DFU and amputations were registered during the 10 following years. The relation between the SAF and later DFU was analyzed by Cox model regression, adjusted for vascular risk factors. The 206 participants were mainly men (55.8%), 51 ± 15 years old, with a 22 ± 13 years diabetes duration. Twelve subjects presented a DFU. Their SAF were higher: 2.61 ± 0.89 AU vs 2.11 ± 0.53 for the others (p = 0.003), related to the risk of DFU (OR:3.69; 95% CI: 1.06-12.79) after adjustment for age, gender, diabetes duration, initial HbA1c, arterial hypertension, history of smoking, blood lipids and use of a statin. Five subjects were amputated, also related to the initial SAF: OR: 11.28 (95% CI: 1.76-79.97) after adjustment for age, gender, duration of diabetes, and HbA1c. The SAF has already been related to diabetic neuropathy and peripheral arterial disease. It predicts DFU in type 1 diabetes, which suggests that AGEs play a role in this highly specific and feared complication.
Collapse
Affiliation(s)
- Saad Rojubally
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Amélie Simoneau
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Marie Monlun
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Ninon Foussard
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Laurence Blanco
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Frédéric Domenge
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Kamel Mohammedi
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Eric Ducasse
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Caroline Caradu
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France
| | - Vincent Rigalleau
- Bordeaux CHU and University, Endocrinology-Diabetology-Nutrition and Vascular Surgery, 33000 Bordeaux, France.
| |
Collapse
|
8
|
Foussard N, Larroumet A, Rigo M, Mohammedi K, Baillet-Blanco L, Poupon P, Monlun M, Lecocq M, Devouge AC, Ducos C, Liebart M, Battaglini Q, Rigalleau V. Skin autofluorescence predicts cancer in subjects with type 2 diabetes. BMJ Open Diabetes Res Care 2021; 9:9/1/e001312. [PMID: 33762312 PMCID: PMC7993362 DOI: 10.1136/bmjdrc-2020-001312] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 02/11/2021] [Accepted: 02/26/2021] [Indexed: 12/16/2022] Open
Abstract
INTRODUCTION Subjects with type 2 diabetes have an excess risk of cancer. The potential role of advanced glycation end products (AGEs) accumulated during long-term hyperglycemia in cancer development has been suggested by biological studies but clinical data are missing. AGEs can be estimated by measuring the skin autofluorescence. We searched whether the skin autofluorescence could predict new cancers in persons with type 2 diabetes. RESEARCH DESIGN AND METHODS From 2009 to 2015, we measured the skin autofluorescence of 413 subjects hospitalized for uncontrolled or complicated type 2 diabetes, without any history of cancer. The participants were followed for at least 1 year and the occurrences of new cancers were compared according to their initial skin autofluorescences. RESULTS The participants were mainly men (57.9%), with poorly controlled (HbA1c 72±14 mmol/mol or 8.7%±1.8%) and/or complicated type 2 diabetes. Their median skin autofluorescence was 2.6 (2.2-3.0) arbitrary units. Forty-five new cancer cases (10.9%) were registered during 4.8±2.3 years of follow-up: 75.6% of these subjects had skin autofluorescence higher than the median (χ2: p=0.001). By Cox regression analysis adjusted for age, gender, body mass index, history of smoking and renal parameters, skin autofluorescence >2.6 predicted a 2.57-fold higher risk of cancer (95% CI 1.28 to 5.19, p=0.008). This association remained significant after excluding the eight cancers that occurred in the 4 years after inclusion (OR 2.95, 95% CI 1.36 to 6.38, p=0.006). As a continuous variable, skin autofluorescence was also related to new cancers (OR 1.05, 95% CI 1.01 to 1.10, p=0.045). CONCLUSIONS Skin autofluorescence, a potential marker of glycemic memory, predicts the occurrence of cancer in subjects with type 2 diabetes. This relation provides a new clinical argument for the role of AGEs in cancer. Their estimation by measuring the skin autofluorescence may help select subjects with diabetes in cancer screening programs.
Collapse
Affiliation(s)
- Ninon Foussard
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Alice Larroumet
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Marine Rigo
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Kamel Mohammedi
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | | | - Pauline Poupon
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Marie Monlun
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Maxime Lecocq
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Anne-Claire Devouge
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Claire Ducos
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Marion Liebart
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Quentin Battaglini
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Vincent Rigalleau
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
- INSERM U1219-Bordeaux Population Health Research Center, Bordeaux, France
| |
Collapse
|
9
|
Rigalleau V, Foussard N, Larroumet A, Monlun M, Blanco L, Delyfer MN, Korobelnik JF, Mohammedi K. Can the skin autofluorescence predict retinopathy in diabetes? Diabet Med 2021; 38:e14499. [PMID: 33319453 DOI: 10.1111/dme.14499] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 12/05/2020] [Accepted: 12/09/2020] [Indexed: 12/19/2022]
Affiliation(s)
- Vincent Rigalleau
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Ninon Foussard
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Alice Larroumet
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Marie Monlun
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Laurence Blanco
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Marie Noëlle Delyfer
- Department of Ophtalmology, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | | | - Kamel Mohammedi
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| |
Collapse
|
10
|
Simoneau A, Rojubally S, Mohammedi K, Monlun M, Foussard N, Rigalleau V, Blanco L. Glucose control and infection of diabetic foot ulcer. J Diabetes Complications 2021; 35:107772. [PMID: 33487541 DOI: 10.1016/j.jdiacomp.2020.107772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Accepted: 10/06/2020] [Indexed: 11/27/2022]
Affiliation(s)
- Amélie Simoneau
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France.
| | - Saad Rojubally
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| | - Kamel Mohammedi
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| | - Marie Monlun
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| | - Ninon Foussard
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| | - Vincent Rigalleau
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| | - Laurence Blanco
- Bordeaux CHU and University, Endocrinology-Nutrition, 33000 Bordeaux, France
| |
Collapse
|
11
|
Monlun M, Foussard N, Blanco L, Mohammedi K, Rigalleau V. Letter to the Editor: "Longitudinal Changes in the Relationship Between Hemoglobin A1c and Glucose Tolerance Across Pregnancy and Post-Partum. J Clin Endocrinol Metab 2021; 106:e389-e390. [PMID: 32589710 DOI: 10.1210/clinem/dgaa397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 06/22/2020] [Indexed: 11/19/2022]
Affiliation(s)
- Marie Monlun
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Ninon Foussard
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Laurence Blanco
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Kamel Mohammedi
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - Vincent Rigalleau
- Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| |
Collapse
|
12
|
Rigalleau V, Foussard N, Bertrand A, Monlun M, Blanco L, Mohammedi K. Lung cancer and diabetes: A role for advanced glycation end-products? Eur J Clin Invest 2021; 51:e13389. [PMID: 32851639 DOI: 10.1111/eci.13389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Revised: 08/19/2020] [Accepted: 08/19/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Vincent Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Alexia Bertrand
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
13
|
Larroumet A, Foussard N, Monlun M, Blanco L, Mohammedi K, Rigalleau V. Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-1919. Diabetes Care 2020; 43:e198. [PMID: 33218982 DOI: 10.2337/dc20-1742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Alice Larroumet
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| | - Ninon Foussard
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| | - Marie Monlun
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| | - Laurence Blanco
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| | - Kamel Mohammedi
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| | - Vincent Rigalleau
- CHU de Bordeaux, Department of Endocrinology-Diabetology-Nutrition, Bordeaux, France
| |
Collapse
|
14
|
Foussard N, Saulnier PJ, Potier L, Ragot S, Schneider F, Gand E, Monlun M, Baillet-Blanco L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S. Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes. Diabetes Care 2020; 43:2751-2759. [PMID: 33055101 DOI: 10.2337/dc20-1085] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Accepted: 08/05/2020] [Indexed: 02/03/2023]
Abstract
OBJECTIVE We evaluated the association between diabetic retinopathy stages and lower-extremity arterial disease (LEAD), its prognostic value, and the influence of potential contributors to this relationship in a prospective cohort of patients with type 2 diabetes. RESEARCH DESIGN AND METHODS Diabetic retinopathy was staged at baseline as absent, nonproliferative, or proliferative. A Cox regression model was fitted in order to compute the hazard ratio (HR) (95% CI) for major LEAD (lower-limb amputation or revascularization) during follow-up by baseline retinopathy stages. The retinopathy-LEAD association was assessed in subgroups by age, sex, diabetes duration, HbA1c, systolic blood pressure, diabetic kidney disease, smoking, and macrovascular disease at baseline. The performance of retinopathy in stratifying LEAD risk was assessed by using the C statistic, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). RESULTS Among 1,320 participants without a history of LEAD at baseline, 94 (7.1%) developed a major LEAD during a 7.1-year median follow-up (incidence rate 9.6 per 1,000 person-years [95% CI 7.8-11.7]). The LEAD incidence rate (per 1,000 person-years) increased as retinopathy worsened: it was 5.5 (95% CI 3.9-7.8) in participants in whom retinopathy was absent, 14.6 (11.1-19.3) in those with nonproliferative retinopathy, and 20.1 (11.1-36.3) in those with proliferative retinopathy. Nonproliferative retinopathy (adjusted HR 2.31 [95% CI 1.43-3.81], P = 0.0006) and proliferative retinopathy (3.14 [1.40-6.15], P = 0.007) remained associated with major LEAD. No heterogeneity was observed across subgroups. Retinopathy enhanced the C statistic (+0.023 [95% CI 0.003-0.044], P = 0.02), IDI (0.209 [0.130-0.321], P < 0.001), and NRI (0.562 [0.382-0.799], P < 0.001) values for risk of LEAD, beyond traditional risk factors. CONCLUSIONS An independent dose-response relationship was identified between diabetic retinopathy stages and major LEAD. Retinopathy yielded incremental prognostic information for stratifying risk of LEAD, suggesting its usefulness as a predictor of LEAD.
Collapse
Affiliation(s)
- Ninon Foussard
- Hôpital Haut-Lévêque, Département d'Endocrinologie, Diabétologie, Nutrition, Pessac, Bordeaux, France
| | - Pierre-Jean Saulnier
- Université de Poitiers, UFR de Médecine et Pharmacie, Poitiers, France.,CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France.,INSERM, CIC 1402, Poitiers, France
| | - Louis Potier
- Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Département de Diabétologie, Endocrinologie, Nutrition, Paris, France.,Université de Paris, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
| | - Stéphanie Ragot
- Université de Poitiers, UFR de Médecine et Pharmacie, Poitiers, France.,CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France.,INSERM, CIC 1402, Poitiers, France
| | - Fabrice Schneider
- Université de Poitiers, UFR de Médecine et Pharmacie, Poitiers, France.,Département de Chirurgie Vasculaire, CHU de Poitiers, Poitiers, France
| | - Elise Gand
- CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France
| | - Marie Monlun
- Hôpital Haut-Lévêque, Département d'Endocrinologie, Diabétologie, Nutrition, Pessac, Bordeaux, France
| | - Laurence Baillet-Blanco
- Hôpital Haut-Lévêque, Département d'Endocrinologie, Diabétologie, Nutrition, Pessac, Bordeaux, France
| | - Gilberto Velho
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
| | - Michel Marre
- Université de Paris, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.,CMC Ambroise Paré, Neuilly-sur-Seine, France
| | - Ronan Roussel
- Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Département de Diabétologie, Endocrinologie, Nutrition, Paris, France.,Université de Paris, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
| | - Vincent Rigalleau
- Hôpital Haut-Lévêque, Département d'Endocrinologie, Diabétologie, Nutrition, Pessac, Bordeaux, France.,Université de Bordeaux, UFR de Médecine, Bordeaux, France.,INSERM U1219 "Bordeaux Population Health," Bordeaux, France
| | - Kamel Mohammedi
- Hôpital Haut-Lévêque, Département d'Endocrinologie, Diabétologie, Nutrition, Pessac, Bordeaux, France .,Université de Bordeaux, UFR de Médecine, Bordeaux, France.,INSERM U1034, Biologie des Maladies Cardiovasculaires, Bordeaux, France
| | | | | |
Collapse
|
15
|
Rigo M, Lecocq M, Brouzeng C, Michelet M, Mohammedi K, Blanco L, Poupon P, Haissaguerre M, Monlun M, Foussard N, Larroumet A, Devouge AC, Ducos C, Bataglini Q, Liébart M, Rigalleau V. Skin autofluorescence, a marker of glucose memory in type 2 diabetes. Metabol Open 2020; 7:100038. [PMID: 32812941 PMCID: PMC7424807 DOI: 10.1016/j.metop.2020.100038] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 04/27/2020] [Accepted: 05/08/2020] [Indexed: 01/26/2023] Open
Abstract
Abstract The accumulation of Advanced Glycation End-products in the tissues studied as a marker of metabolic memory. Skin autofluorescence as a marker of glycemic memory in type 2 diabetes. Skin autofluorescence was independently related to their most ancient HbA1c. Skin autofluorescence was higher in subjects with microangiopathic complications.
Collapse
Affiliation(s)
- Marine Rigo
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Maxime Lecocq
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Charlotte Brouzeng
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Marie Michelet
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Kamel Mohammedi
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Laurence Blanco
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Pauline Poupon
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | | | - Marie Monlun
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Ninon Foussard
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Alice Larroumet
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Anne-Claire Devouge
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Claire Ducos
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Quentin Bataglini
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Marion Liébart
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| | - Vincent Rigalleau
- CHU de Bordeaux, Department of Nutrition-Diabetology, Bordeaux, F-33000, France
| |
Collapse
|
16
|
Monlun M, Foussard N, Blanco L, Mohammedi K, Rigalleau V. Re: "Timing of Gestational Diabetes Diagnosis by Maternal Obesity Status: Impact on Gestational Weight Gain in a Diverse Population" by Hillier et al. J Womens Health (Larchmt) 2020; 29:1234. [PMID: 32813608 DOI: 10.1089/jwh.2020.8616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Marie Monlun
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Vincent Rigalleau
- Department of Endocrinology-Nutrition, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
17
|
Rigalleau V, Bertrand A, Rojubally S, Majchrzak C, Bocock O, Foussard N, Monlun M, Blanco L, Mohammedi K. Continuous subcutaneous insulin infusion and neuropathy in older people. Diabet Med 2020; 37:1208-1209. [PMID: 32276296 DOI: 10.1111/dme.14302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/01/2020] [Indexed: 11/30/2022]
Affiliation(s)
- V Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - A Bertrand
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - S Rojubally
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - C Majchrzak
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - O Bocock
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - N Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - M Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - L Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - K Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| |
Collapse
|
18
|
Larroumet A, Rigo M, Lecocq M, Delyfer MN, Korobelnik JF, Monlun M, Foussard N, Poupon P, Blanco L, Mohammedi K, Rigalleau V. Previous dramatic reduction of HbA1c and retinopathy in Type 2 Diabetes. J Diabetes Complications 2020; 34:107604. [PMID: 32360194 DOI: 10.1016/j.jdiacomp.2020.107604] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 04/20/2020] [Accepted: 04/20/2020] [Indexed: 01/03/2023]
Abstract
AIMS Does Diabetic Retinopathy (DR) relate to a previous dramatic reduction of HbA1c in Type 2 Diabetes (T2D)? METHODS In patients hospitalized for T2D, we collected HbA1c values from previous years, and we defined "Rapid declinors" by a more than -3% reduction between two consecutive HbA1c, and "sustained moderate declinors" by HbA1c declining less than -3%. We analyzed the relation between DR and previous HbA1c courses, adjusted for other risk factors. RESULTS Our 680 patients had a mean HbA1c at 8.7 ± 1.7% at admission and 8.7 ± 1.8 to 9.0 ± 2.2% during previous years (1500 HbA1C values collected), and 24% had a DR. A previous rapid decline of HbA1c occurred in 13.5% of subjects and related to DR (OR = 1.86, 95%CI:1.02-3.40), especially proliferative (OR = 2.64, 95%CI:1.02-6.80), after adjustment for age, gender, body mass index, arterial hypertension and diabetic kidney disease, blood lipids and statin treatment, duration of diabetes and mean previous HbA1c. A previous moderate reduction of HbA1c as occurred in 28.3% other subjects was not related to DR. CONCLUSIONS In subjects hospitalized for T2D, a previous rapid decline of HbA1c was related to proliferative DR, whereas a sustained moderate decline appeared to be safe.
Collapse
Affiliation(s)
- Alice Larroumet
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | - Marine Rigo
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | | | - Marie-Noelle Delyfer
- Ophthalmology, CHU de Bordeaux, France; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA,UMR 1219, F-33000 Bordeaux, France
| | - Jean-François Korobelnik
- Ophthalmology, CHU de Bordeaux, France; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA,UMR 1219, F-33000 Bordeaux, France
| | - Marie Monlun
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | - Ninon Foussard
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | - Pauline Poupon
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | - Laurence Blanco
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France
| | - Kamel Mohammedi
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France; Ophthalmology, CHU de Bordeaux, France; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA,UMR 1219, F-33000 Bordeaux, France
| | - Vincent Rigalleau
- Department of Endocrinology-Diabetology-Nutrition, CHU de Bordeaux, France; Ophthalmology, CHU de Bordeaux, France; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA,UMR 1219, F-33000 Bordeaux, France.
| |
Collapse
|
19
|
Ducos C, Rigo M, Larroumet A, Delyfer MN, Korobelnik JF, Monlun M, Foussard N, Poupon P, Haissaguerre M, Blanco L, Mohammedi K, Rigalleau V. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory. Diabetes Metab 2020; 47:101156. [PMID: 32387701 DOI: 10.1016/j.diabet.2020.03.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2019] [Revised: 03/18/2020] [Accepted: 03/31/2020] [Indexed: 01/25/2023]
Abstract
AIMS As diabetic retinopathy (DR) can occur even in well-controlled patients with type 2 diabetes (T2D), our study sought to determine whether it might be related to 'glucose memory' by evaluating patients' HbA1c over previous years and their skin autofluorescence (SAF). METHODS In 334 patients with T2D and HbA1c levels≤8%, their available values of HbA1c from previous years were collected, and their SAF measured by an advanced glycation end-product (AGE) reader. Binary logistic regression analysis was then used to correlate DR with previously recorded HbA1c levels and to SAF, with adjustment for DR risk factors [age, gender, BMI, duration of diabetes, arterial hypertension, diabetic kidney disease (DKD), blood lipid levels and statin treatment]. RESULTS Our patients were mostly men (58.4%) aged 63±10years, with a duration of diabetes of 13±10years and HbA1c=7.1±0.7%. Of these patients, 84 (25.1%) had DR, which was associated with longer duration of diabetes and greater prevalence of DKD. A total of 605 HbA1c values from previous years were collected for time periods -4±3 months (n=255), -16±4months (n=152), -30±4months (n=93) and -62±26 months (n=105). After adjustment, the association between DR and having an HbA1c higher than the median was significant only for the oldest previous HbA1c values: OR=6.75, 95% CI: 1.90-23.90. Moreover, SAF values were higher in those with DR [2.95±0.67 arbitrary units (AU)] vs 2.65±0.65 AU with no DR (P<0.01) and were also associated with the oldest previous HbA1c values (P<0.01). CONCLUSION Our study found that 25.1% of our well-controlled T2D patients had DR, which was related to both their HbA1c levels from 5years prior to study admission and their SAF values, a marker of glucose memory.
Collapse
Affiliation(s)
- C Ducos
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France.
| | - M Rigo
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - A Larroumet
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M-N Delyfer
- Department of Ophthalmology, CHU de Bordeaux, 33000 Bordeaux, France
| | - J-F Korobelnik
- Department of Ophthalmology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M Monlun
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - N Foussard
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - P Poupon
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M Haissaguerre
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - L Blanco
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - K Mohammedi
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - V Rigalleau
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| |
Collapse
|
20
|
Simoneau A, Blanco L, Domenge F, Mohammedi K, Foussard N, Monlun M, Poupon P, Rigalleau V. Comment on "Ulcer-free survival days and ulcer healing in patients with diabetic foot ulcers: A prospective cohort study". Int Wound J 2020; 17:228-229. [PMID: 31691495 PMCID: PMC7948696 DOI: 10.1111/iwj.13225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Accepted: 09/01/2019] [Indexed: 11/30/2022] Open
Affiliation(s)
- Amélie Simoneau
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Laurence Blanco
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Frédéric Domenge
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Kamel Mohammedi
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Ninon Foussard
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Marie Monlun
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Pauline Poupon
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - Vincent Rigalleau
- Endocrinology‐Nutrition DepartmentCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| |
Collapse
|
21
|
Foussard N, Baillet-Blanco L, Poupon P, Monlun M, Mohammedi K, Cougnard-Grégoire A, Delcourt C, Helmer C, Rigalleau V. Markers of glycation and neonatal hypoglycaemia in gestational diabetes mellitus. Diabet Med 2020; 37:160-162. [PMID: 31693204 DOI: 10.1111/dme.14167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- N Foussard
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - L Baillet-Blanco
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - P Poupon
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - M Monlun
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - K Mohammedi
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - A Cougnard-Grégoire
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - C Delcourt
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - C Helmer
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - V Rigalleau
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| |
Collapse
|
22
|
Ducos C, Rigalleau V, Foussard N, Cambos S, Poupon P, Monlun M, Blanco L, Haissaguerre M, Grouthier V, Velayoudom-Cephise FL, Mohammedi K. Why might pumps fail in pregnant women with Type 1 diabetes? Diabet Med 2020; 37:159-160. [PMID: 31264729 DOI: 10.1111/dme.14063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/01/2019] [Indexed: 11/26/2022]
Affiliation(s)
- C Ducos
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - V Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - N Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - S Cambos
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - P Poupon
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - M Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - L Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - M Haissaguerre
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - V Grouthier
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - F-L Velayoudom-Cephise
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - K Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| |
Collapse
|
23
|
Devouge AC, Foussard N, Poupon P, Monlun M, Blanco L, Mohammedi K, Rigalleau V. Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675-1683. Diabetes Care 2019; 42:e189-e190. [PMID: 31748217 DOI: 10.2337/dc19-1504] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Anne-Claire Devouge
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Ninon Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Pauline Poupon
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Vincent Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| |
Collapse
|
24
|
Foussard N, Cambos S, Poupon P, Monlun M, Blanco L, Haissaguerre M, Grouthier V, Velayoudom-Cephise FL, Mohammedi K, Rigalleau V. Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810-815. Diabetes Care 2019; 42:e122. [PMID: 31221708 DOI: 10.2337/dc19-0446] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Ninon Foussard
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Sophie Cambos
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Pauline Poupon
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Magalie Haissaguerre
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Virginie Grouthier
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Fritz-Line Velayoudom-Cephise
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Vincent Rigalleau
- Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| |
Collapse
|
25
|
Stankevich L, Galhaud JP, Kuvshinov R, Helmer C, Poupon P, Blanco L, Monlun M, Foussard N, Mohammedi K, Rigalleau V. Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A 1c Testing. Diabetes Care 2019;42:576-584. Diabetes Care 2019; 42:e102. [PMID: 31110126 DOI: 10.2337/dc19-0375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
| | | | | | - Catherine Helmer
- Population Health Research Center, Inserm UMR 1219, Université de Bordeaux, Bordeaux, France
| | - Pauline Poupon
- Population Health Research Center, Inserm UMR 1219, Université de Bordeaux, Bordeaux, France.,Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Population Health Research Center, Inserm UMR 1219, Université de Bordeaux, Bordeaux, France.,Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Vincent Rigalleau
- Population Health Research Center, Inserm UMR 1219, Université de Bordeaux, Bordeaux, France .,Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
26
|
Camoin M, Delyfer MN, Korobelnik JF, Mohammedi K, Blanco L, Foussard N, Poupon P, Monlun M, Haissaguerre M, Rigalleau V. Comment on Pongrac Barlovic et al. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up. Diabetes Care 2018;41:2487-2494. Diabetes Care 2019; 42:e48. [PMID: 30787063 DOI: 10.2337/dc18-2202] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Marion Camoin
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Marie-Noelle Delyfer
- Ophthalmology Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Jean-François Korobelnik
- Ophthalmology Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Pauline Poupon
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Magalie Haissaguerre
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Vincent Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
27
|
Rigalleau V, Lecocq M, Rigo M, Monlun M, Poupon P, Blanco L, Alexandre L, Haissaguerre M, Mohammedi K. Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962. Diabetes Care 2018; 41:e147. [PMID: 30348848 DOI: 10.2337/dc18-1543] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Vincent Rigalleau
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Maxime Lecocq
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Marine Rigo
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Pauline Poupon
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Laure Alexandre
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Magali Haissaguerre
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Department of Nutrition-Diabetology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| |
Collapse
|
28
|
Rigalleau V, Benoit J, Charret L, Bertrand C, Foussard N, Blanco L, Alexandre L, Monlun M, Mohammedi K. Longitudinal trends in HbA1c in diabetes: Stable means can hide meaningful long-term changes. Diabetes Metab Res Rev 2018; 34:e3065. [PMID: 30123984 DOI: 10.1002/dmrr.3065] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Revised: 07/02/2018] [Accepted: 07/29/2018] [Indexed: 12/13/2022]
Affiliation(s)
- Vincent Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Julie Benoit
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Léa Charret
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Capucine Bertrand
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Ninon Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Laure Alexandre
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
29
|
Monlun M, Hugo M, Blanco L, Mohammedi K, Ahdab R, Alexandre L, Poirot-Mazeres S, Rajaobelina K, Rigalleau V. Nerve action potential amplitude, a robust marker of diabetic peripheral neuropathy. Diabet Med 2018; 35:1460-1461. [PMID: 29791761 DOI: 10.1111/dme.13690] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Monlun
- Bordeaux CHU, Endocrinology-Nutrition, Bordeaux
| | - M Hugo
- Bordeaux CHU, Endocrinology-Nutrition, Bordeaux
| | - L Blanco
- Bordeaux CHU, Endocrinology-Nutrition, Bordeaux
| | - K Mohammedi
- APHP, Department of Endocrinology, Bichat Hospital, Paris
| | - R Ahdab
- Division of Neurology, LAUMC-RH, Beirut, Lebanon
| | - L Alexandre
- Bordeaux CHU, Endocrinology-Nutrition, Bordeaux
| | | | | | - V Rigalleau
- Bordeaux CHU, Endocrinology-Nutrition, Bordeaux
| |
Collapse
|
30
|
Azar M, Coirier E, Delyfer MN, Korobelnik JF, Mohammedi K, Blanco L, Alexandre L, Monlun M, Rigalleau V. Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815-822. Diabetes Care 2018; 41:e127. [PMID: 29934488 DOI: 10.2337/dc18-0510] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Marie Azar
- Ophthalmology Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - Elise Coirier
- Ophthalmology Department, Centre Hospitalier Universitaire de Bordeaux, France
| | | | | | - Kamel Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - Laurence Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - Laure Alexandre
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - Marie Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - Vincent Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| |
Collapse
|
31
|
Blanc-Bisson C, Velayoudom-Cephise FL, Cougnard-Gregoire A, Helmer C, Rajaobelina K, Delcourt C, Alexandre L, Blanco L, Mohammedi K, Monlun M, Rigalleau V. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study. Cardiovasc Diabetol 2018; 17:82. [PMID: 29884175 PMCID: PMC5993997 DOI: 10.1186/s12933-018-0718-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Accepted: 05/17/2018] [Indexed: 01/10/2023] Open
Abstract
Background Advanced glycation end-products play a role in diabetic vascular complications. Their optical properties allow to estimate their accumulation in tissues by measuring the skin autofluorescence (SAF). We searched for an association between SAF and major adverse cardiovascular events (MACE) incidence in subjects with Type 1 Diabetes (T1D) during a 7 year follow-up. Methods During year 2009, 232 subjects with T1D were included. SAF measurement, clinical [age, sex, body mass index (BMI), comorbidities] and biological data (HbA1C, blood lipids, renal parameters) were recorded. MACE (myocardial infarction, stroke, lower extremity amputation or a revascularization procedure) were registered at visits in the center or by phone call to general practitioners until 2016. Results The participants were mainly men (59.5%), 51.5 ± 16.7 years old, with BMI 25.0 ± 4.1 kg/m2, diabetes duration 21.5 ± 13.6 years, HbA1C 7.6 ± 1.1%. LDL cholesterol was 1.04 ± 0.29 g/L, estimated Glomerular Filtration Rates (CKD-EPI): 86.3 ± 26.6 ml/min/1.73 m2. Among these subjects, 25.1% were smokers, 45.3% had arterial hypertension, 15.9% had elevated AER (≥ 30 mg/24 h), and 9.9% subjects had a history of previous MACE. From 2009 to 2016, 22 patients had at least one new MACE: 6 myocardial infarctions, 1 lower limb amputation, 15 revascularization procedures. Their SAF was 2.63 ± 0.73 arbitrary units (AU) vs 2.08 ± 0.54 for other patients (p = 0.002). Using Cox-model, after adjustment for age (as the scale time), sex, diabetes duration, BMI, hypertension, smoking status, albumin excretion rates, statin treatment and a previous history of MACE, higher baseline levels of SAF were significantly associated with an increased risk of MACE during follow-up (HR = 4.13 [1.30–13.07]; p = 0.02 for 1 AU of SAF) and Kaplan–Meier curve follow-up showed significantly more frequent MACE in group with SAF upper the median (p = 0.001). Conclusion A high SAF predicts MACE in patients with T1D. Electronic supplementary material The online version of this article (10.1186/s12933-018-0718-8) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- C Blanc-Bisson
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France.
| | - F L Velayoudom-Cephise
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| | - A Cougnard-Gregoire
- INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Univ Bordeaux, 33000, Bordeaux, France
| | - C Helmer
- INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Univ Bordeaux, 33000, Bordeaux, France
| | - K Rajaobelina
- INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Univ Bordeaux, 33000, Bordeaux, France
| | - C Delcourt
- INSERM, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Univ Bordeaux, 33000, Bordeaux, France
| | - L Alexandre
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| | - L Blanco
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| | - K Mohammedi
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| | - M Monlun
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| | - V Rigalleau
- Nutrition Diabetology Unit, CHU Bordeaux, Haut-Levêque Hospital, Avenue Magellan, 33600, Pessac Cedex, France
| |
Collapse
|
32
|
Simoneau A, Monlun M, Poupon P, Baillet-Blanco L, Alexandre L, Mohammedi K, Rigalleau V. Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232. Diabetes Care 2018; 41:e35-e36. [PMID: 29463673 DOI: 10.2337/dc17-2175] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Amélie Simoneau
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Marie Monlun
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Pauline Poupon
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | | | - Laure Alexandre
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Kamel Mohammedi
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Vincent Rigalleau
- Nutrition-Diabétologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| |
Collapse
|
33
|
Affiliation(s)
- M Monlun
- Department of Endocrinology and Nutrition, Centre Hospitalier Universitaire de Bordeaux, France
| | - L Blanco
- Department of Endocrinology and Nutrition, Centre Hospitalier Universitaire de Bordeaux, France
| | - L Alexandre
- Department of Endocrinology and Nutrition, Centre Hospitalier Universitaire de Bordeaux, France
| | - K Mohammedi
- Department of Endocrinology and Nutrition, Centre Hospitalier Universitaire de Bordeaux, France
| | - V Rigalleau
- Department of Endocrinology and Nutrition, Centre Hospitalier Universitaire de Bordeaux, France
| |
Collapse
|